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Abstract
Introduction: Endovascular aneurysm repair (EVAR) is the 
therapy of choice in high risk patients with abdominal aortic 
aneurysm. The good results described are leading to the 
broadening of clinical indications to younger patients. However, 
reintervention rates seem higher and even with successful 
treatment sometimes there is growth of the aneurysm sac and 
rupture, meaning a failure of the therapeutic goal. This study 
proposes to analyse the impact of age in patients’ selection and 
post-EVAR results. 
Methods: The clinical records of consecutive patients 
undergoing endovascular aneurysm repair, between 2001 and 
2013, were retrospectively reviewed. Patients were divided 
according to age groups (<70, 70-80 and >80 years). Gender, body 
mass index, aneurysm anatomic features, neck characteristics, 
iliac morphology, surgical indication, endograft type, anesthesic 
risk classification, length of stay, reinterventions and mortality 
were analysed and compared. 
Results: The study included 171 patients, 161 (94.1%) men, 
and mean age 74.1±8.9 years. The age group under 70 had 32% 
of the patients. Only three characteristics were found different 
among age groups: 1) body mass index was higher in younger 
patients, with a considerable trend toward significance (P=0.06); 
2) surgical indication, in the younger group, surgeon’s and the 
patient’s option were more proeminent (P<0.05); 3) erectile 
dysfunction was higher in elderly group (P<0.05). No other 
clinical and anatomical characteristics or final outcomes were 
found statisticaly different among age groups. 
Conclusion: The absence of statistically differences in 
mortality and reinterventions among age groups suggests that 
age by itself is not a relevant factor in endovascular aneurysm 
repair. Indeed, the three characteristics different in younger 
(obesity, sexual function and patient’s choice) favor endovascular 
aneurysm repair.
Keywords: Age Groups. Aortic Aneurysm, Abdominal. 
Endovascular Procedures.
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INTRODUCTION 
Since Parodi’s publication in 1991 about the first 
endovascular aneurysm repair (EVAR)[1], this therapy has been 
widely used in elderly and high-risk patients. Several randomized 
controlled trials showed less mortality, a shorter length of stay, 
lower consumption of blood products, and a better short-
term quality of life with EVAR[2-5]. When it comes to younger 
patients, it is imperative to question the procedure’s durability, 
reintervention rates, and the probability of aneurysm sac growth 
and rupture. The purpose of this study is to investigate if there is 
any association of age during EVAR, clinical characteristics of the 
patients and the outcomes of the procedure compared among 
different age groups.
METHODS
The clinical records of consecutive patients undergoing EVAR 
for infrarenal abdominal aortic aneurysm (AAA) or aortoiliac 
aneurysms between October 2001 and December 2013 in 
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our department were retrospectively reviewed. All surgeries 
took place in an operation room equipped with a Philips BV 300 
C-Arm and a radiolucent table, and were performed by the same 
surgical team. The surgical criteria were infra-renal fusiforme AAA 
with diameter equal or superior to 5 cm and AAA associated with 
iliac aneurysms with diameter equal or superior to 3 cm, saccular 
aneurysms and false aneurysms. The endografts used were 
Talent Bi- and Uni-Iliac (suprarenal fixation, by friction) and Gore-
Excluder Bi-Iliac (infrarenal fixation, by barbs); after October 2008 
the Endurant Bi- and Uni-Iliac (suprarenal fixation, by hooks) were 
used. Patients were divided by age. The groups were: patients 
younger than 70 years old, 70 to 80 years old and older. Sex, 
atherosclerotic risk factors (hypertension, diabetes, smoke history, 
dyslipidemia), cerebrovascular disease, peripheral arterial disease, 
body mass index (BMI), anatomic features, aneurysm diameter, 
neck characteristics (diameter, angulation, length, calcification, 
thrombus), iliac morphology (tortuosity and diameter), anatomical 
risks, internal iliac artery aneurysm, surgical indication for EVAR, 
endograft type, American Society of Anesthesiologists (ASA) 
classification, anesthetic technique, length of stay, re-interventions, 
mortality, and costs were analyzed and compared. 
Statistical Analysis
Statistical analysis included t-tests for two independent samples, 
analyses of variance in the case of several groups, and chi-square 
tests for the comparison of categorical variables. Nonparametric 
tests were used when the normality or homogeneity of variances 
was not observed. All the analyses were performed using IBM SPSS 
Statistics, version 22; the statistical significance of two-sided tests 
was assumed to be P<0.05.
RESULTS
One hundred and seventy-one patients, of which 94.2% 
(161/171) were men, underwent EVAR. The mean age was 74.1 
years and the median was 75, with a standard deviation of 8.9 
(min.: 38; max.: 93). The under-70 age group had 32% of the 
patients, 38.4% were between 70 and 80 years old, and 29.7% 
were more than 80 years old. The median time of follow-up was 
32.7±29.8 months.
Pre-, intra-, and postoperative data are shown in Table 1. 
Atherosclerotic risk factors, cerebrovascular and peripheral 
arterial disease and BMI are shown in Table 2. Younger patients 
had a higher BMI, near to statistical significance (P=0.06).
Regarding erectile function, 44.6% patients, with mean age 
of 75.5±7.2 years, presented dysfunction pre-EVAR, compared to 
55.4% patients with erectile function preserved, with a mean age 
of 70±8.7 years. This age difference was statistically significant 
(P<0.05). Grouping erectile dysfunction by age, there is an 
obvious tendency for it to increase with age (Figure 1). The need 
for blood transfusion during hospitalization was also higher in 
older patients, as shown in Figure 2, and this difference was 
statistically significant (P<0.05).
Indications for EVAR were divided in a high-risk profile (clinical 
+ hostile abdomen), surgeon’s option, and patient’s option. In 
the under-70 age group, the decisions were 73.6%, 15.1%, and 
11.3%, respectively; in the 70–80 age group, they were 80%, 
12.3%, and 7.7%, respectively, and in the age >80 group they 
were 98%, 2%, and 0%, respectively. There was a statistically 
significant difference among the age groups and indication 
for EVAR: in the younger group, the surgeons’ and the patients’ 
options were more frequent. The types of endografts used are 
described in Table 3.
Anatomic risk factors for EVAR were defined as a neck 
angle >50º, a neck diameter >28 mm, a neck length <10 mm, 
calcification of >50% of the neck circumference, thrombus >50% 
of the neck circumference, iliac diameter >20 mm, and iliac tortuosity. 
In Figure 3, we divided the number of risk factors presented into 0, 1, 
Fig. 2 - Blood transfusion during hospitalization by age group, 
P=0.04.
Fig. 1 – Pre-EVAR erectile dysfunction by age group; P=0.074.
P=0.074
Erectile dysfunction Erectile function preserved
P=0.05
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and 2 or more risk factors by age groups. No significant relationship 
was found between risk factors and age groups.
We reported no statistical difference in the incidence and 
type of endoleak, as shown in Tables 4 and 5, or in aneurysmal 
sac behavior (Table 6).
Two deaths were registered on the 30th day of the follow-up 
period, both in the >80 age group. The global mortality rate was 
1.2% (2/171).
Figure 4 presents 12-year cumulative survival after EVAR. 
Estimating the effect of age, we found that survival in the 
youngest age group (>70 years) was higher but with no statistical 
significance.
The mean procedure cost for patients with <70 years was 
11.658€, for patients between 70-80 years was 11.110,3€, and for 
patients with >80 years, the cost was 11.521,8€ (Table 7).
DISCUSSION
It is the consensus that EVAR is indicated in elderly and high-
risk patients. However, in light of good results, the indication for 
EVAR has been progressively extended to younger and less high-
risk patients, and also to patients with added anatomical risks. So, 
it is fair to question if age is an important factor in choosing EVAR 
as the best therapeutic choice.
ASA
II III IV II III IV II III IV
22.6% 64.2% 13.2% 16.1% 69.4% 14.5% 6.4% 80.9% 12.7%
Anaesthesia 
General Local Loco-regional General Local Loco-regional General Local Loco-regional
38% 0% 62% 42.2% 4.7% 53.1% 23.4% 6.4% 70.2%
Length of Stay 7.2 days (min 2 ; max 60) 6.17 days (min 1 ; max 40) 5.54 days (min 2 ; max 15)
Re-Intervention 9.3% 21.2% 17.6%
30-day Mortality 0% 0% 3.9%
Table 1. Pre, intra and postoperative data. No statistical significance. IIA, Internal Iliac Artery; CIA, Common Iliac Artery; ASA, 
American Society of Anaesthesiologists classification.
< 70 years 70-80 years > 80 years
Aneurysm 
Morphology
Aortic
Right 
AortoIliac
Left
AortoIliac
Bilateral
AortoIliac
Aortic
Right 
AortoIliac
Left
AortoIliac
Bilateral
AortoIliac
Aortic
Right 
AortoIliac
Left
AortoIliac
Bilateral
AortoIliac
30.4% 34.6% 38.5% 30% 41.1% 30.8% 53.8% 45% 28.6% 34.6% 7.7% 45%
IIA Aneurysm 5.8% 12.1% 12%
Aneurysm 
Diameter
61.7mm (min 27 ; max 104) 61.2mm (min 30 ; max 106) 64.5 (min 25 ; max 103)
Neck
Diameter
22mm (min 16 ; max 30) 22.8 (min 18 ; max 33) 22.8mm (min 16 ; max 32)
Neck Length 22.5 (min 10 ; max 70) 22.9mm (min 10 ; max 80) 23.6mm (min 6 ; max 50)
Neck Shape
Straight Conical Inverted Other Straight Conical Inverted Other Straight Conical Inverted Other
62% 28% 6% 4% 61.4% 29.8% 3.5% 5.3% 69.8% 26.5% 4.7% 0%
Calcification
<50% >50% None <50% >50% None <50% >50% None
75% 25% 0% 68.3% 26.7% 5% 64.3% 26.2% 4.5%
Thrombus
None <25% 25-50% 50-75% >75% None <25% 25-50% 50-75% >75% None <25% 25-50% 50-75% >75%
79.2% 2.1% 6.3% 10.4% 2.1% 63.8% 6.9% 10.3% 17.2% 1.7% 70.7% 4.9% 12.2% 7.3% 4.9%
Angulation
None <50º >50º None <50º >50º None <50º >50º
24.5% 42.9% 32.7% 18.6% 47.5% 33.9% 9.5% 52.4% 38.1%
Iliac Tortuosity
Small Medium Large Small Medium Large Small Medium Large
43.2% 37.8% 18.9% 33.3% 44.4% 22.2% 19% 38.1% 42.9%
Right CIA 
Diameter
<20mm >20mm <20mm >20mm <20mm >20mm
85.7% 14.3% 78.9% 21.1% 83.3% 17.7%
Left CIA 
Diameter
<20mm >20mm <20mm >20mm <20mm >20mm
72% 28% 78.9% 21.1% 83.3% 17.7%
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Table 2. Atherosclerotic risk factors, cerebrovascular disease, peripheral arterial disease and body mass index (kg/m2), by age group. 
Age groups
< 70 years 70-80 years > 80 years SS
Hypertension 83.3% 90.9% 76.5% N
Active smokers 38.9% 7.7% 3.9% N
Former smokers 48.1% 70.8% 54.9% N
Dyslipidemia 66.7% 73.8% 60.8% N
Diabetes 20.4% 13.8% 21.6% N
Cerebrovascular disease 24.1% 26.2% 5.9% N
Peripheral arterial disease 18.5% 21.5% 13.7% N
Atherosclerotic risk factors 
association
No risk factors 25% 25% 25%
N
1-2 risk factors 32.6% 30.2% 37.2%
3-4 risk factors 30.9% 41.5% 27.7%
5 or + risk factors 38.9% 55.6% 5.6%
BMI
< 25 kg/m2 30.6% 34% 60.4%
P=0.0625-30 kg/m2 38.8% 41.5% 33%
> 30 kg/m2 30.6% 24.5% 17.7%
SS =statistical significance; Y=yes; N=no
Table 3. Type of endograft used.
< 70 years 70-80 years > 80 years
Endograft
Excluder
Endurant Talent
Excluder
Endurant Talent
Excluder
Endurant Talent
Bi-Iliac Uni-Iliac Bi-Iliac Uni-Iliac Bi-Iliac Uni-Iliac Bi-Iliac Uni-Iliac Bi-Iliac Uni-Iliac Bi-Iliac Uni-Iliac
42.59% 25.93% 16.6% 1.85% 7.41% 36.29% 32.31% 21.54% 4.62% 4.62% 24.49% 57% 22.45% 6.12% 14.29%
No statistical significance.
Table 4. Presence of endoleak by age group.
Age group No endoleak With endoleak
<70 years 63% 37%
70-80 years 56.3% 43.7%
>80 years 59.6% 40.4%
No statistical significance.
Fig. 3 - EVAR risk factors association by age group; no statistical 
significance. 
No risk factors 1 risk factor  2 or more risks factors
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Table 5. Type of endoleak by age group. 
Age Group No endoleak Endoleak I or III Endoleak II Endoleak II + I/III
<70 years 63% 3.7% 25.9% 7.4%
70-80 years 56.3% 12.5% 28.1% 3.1%
>80 years 59.6% 12.8% 19.1% 8.5%
No statistical significance.
Table 6. Aneuysmal sac behavior after EVAR. 
<70 years 70–80 years >80 years
Sac growth 8.0% 11.3% 13.3%
Sac shrinkage
0–5 mm 26.0% 16.1% 24.4%
5–10 mm 30.0% 32.3% 33.3%
10–15 mm 6.0% 14.5% 17.8%
15–20 mm 8.0% 14.5% 4.4%
20–25 mm 8.0% 6.5% 2.2%
25–30 mm 8.0% 1.6% 2.2%
>30 mm 6.0% 3.2% 2.2%
No statistical significance.
EVAR growth has been overwhelming. Albuquerque et al.[6] 
documented a significant increase in the number of EVARs 
performed between 2005 and 2008, with an average rate of 84%, 
compared to a rate of 42.2% between 1996 and 2002. Schwarze 
et al.[7] reported a 162% increase for patients >85 years old 
between 2001 and 2006. For those younger (50–64 years old), 
the increase was less pronounced. Still, in 2005 and 2006, for this 
age group EVAR was already a commonly chosen procedure.
A factor to consider when choosing a therapy is the life 
expectancy of this group of patients. Altaf et al.[8] mentioned 
that independently of the technique used in AAA treatment, in 
young patients, the mortality rate in 6 years was 40%, with most 
of the deaths unrelated to the aneurysm. Darwood et al.[9] stated 
that the group of patients with aneurysms 4–5.4 cm in diameter 
diagnosed by a screening in Gloucestershire had a 10-year 
mortality of 58%. Therefore, the survival rate of the patient with 
an AAA can be much lower than that of the general population.
Mani et al.[10], using the Swedish Vascular Registry from 1987 
to 2005, published a 5-year survival rate of 69% and a 10-year 
survival rate of 39.3% after elective correction of AAAs. Mean 
survival was 8.9 years (99% CI: 8.7–9.2). No significant difference 
in relative survival was observed among different age groups. 
In our study, we estimated survival curves of 9.9 years for those 
younger than 70 years, 7.2 years for those aged 70–80 years, and 
8.3 years for the elderly, those over 80 years old.
The published randomized trials EVAR-1[2,11], DREAM[3], and 
OVER[4], comparing EVAR with conventional surgery, showed that 
early death rates were lower with EVAR (1.7% vs. 4.7%, P=0.009; 
1.2% vs. 4.6%, P=0.10; and 0.5% vs. 3%, P=0.004, respectively). 
EVAR-1[11] showed higher reintervention rates, all graft related 
(23.2% vs. 8.9%, P<0.001). The OVER study included laparotomy-
related complications (incisional hernia, bowel ischemia or 
obstruction) and showed similar reintervention rates (22.1% vs. 
17.8%, P=0.12); the time to a secondary therapeutic procedure 
or death was also similar (1.06 years, P=0.57).
The ACE study showed a death rate higher with EVAR 
compared to conventional surgery (1.6% vs. 0.6%, P=0.09, not 
statistically significant) and a higher reintervention rate (16% vs. 
2.7%, P<0.0001), but reinterventions for incisional repair were not 
recorded[5].
In our study, a global mortality of 1.2% (very similar to the 
mortality rates published in the literature after EVAR) was noted. 
By age group, zero mortality was noted in both the <70 and 70-80 
age groups, and two deaths were registered in the >80 age group 
(2/51, 3.9%). Although not statistically significant, the trend to 
lower mortality suggested the safety of EVAR in younger people.
Fig. 4 - In the population below 70 years, the median survival were 9.9 
years, standard deviation 0.7 (CI 95 – 8.5 to 11.2). The population with 70-
80 years had a median survival of 7.2 years, standard deviation 0.7 (CI 95 
– 5.8 to 8.6). The patients older than 80 years had a median survival of 8.3 
years, standard deviation 1 (CI 95 – 6.4 to 10.3).
< = 69
70 - 79
> = 80
< = 69 - censored
70 - 79 - censored
> = 80 - censored
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Reinterventions seem to be more frequent after EVAR, but the 
majority are minor endovascular reinterventions with relatively 
low 30-day mortality, as stated by Giles et al.[12]. Recently, Lee et 
al.[13] described a nonsignificant difference in the reintervention 
rate between EVAR (16%) and conventional surgery (12%) in a 
single center retrospective review. In our study, there was no 
statistical difference in reinterventions among different age 
groups. Indeed, the number of reinterventions was smaller in 
younger groups: 9.3% (<70 years old), 21.2% (70-80 years old), 
and 17.6% (>80 years old).
The EVAR-2 study compared a set of patients unfit for open 
repair[14]. This study is the closest to our experience, as the majority 
of our patients submitted to EVAR had clinical contraindications 
for open surgery. In EVAR-2 this group was submitted to EVAR 
or underwent clinical follow-up. This study showed a higher 
death rate with EVAR compared to the EVAR-1 study (9% vs. 
2.1%). However, Lim et al.[15], applying the same criteria as EVAR-
2, had mortality rates much lower and similar to the remaining 
literature.
The population study made by Schernerhorn et al.[16] 
comparing EVAR with open repair revealed a mortality rate of 
1.2% vs. 4.8%, respectively. The benefits of EVAR were still present 
after three years of follow-up, when both procedures’ results were 
matched. In the 64-74-year-old age, the results are comparable 
after the first year, while in the group of patients over 85 years 
old there was still an advantage for the EVAR procedure in the 
fourth year.
The indication for EVAR in young patients can be questioned 
after Schanzer’s et al.[17] publication. This analysis revealed that 
5 years after EVAR, there was aneurysm sac growth over 5 mm 
in 41% of patients. The predisposing factors to this growth were 
conical aortic neck, aortic neck diameter >28 mm, neck angle 
>60º, iliac diameter >20 mm, and the presence of an endoleak. 
As younger patients had a longer life expectancy, it seems to also 
present a higher risk of sac growth. However, in this study, the 
primary determinant of AAA sac enlargement was the presence 
of an endoleak, and the majority of endoleaks (76%) became 
evident during the first year post-EVAR. Besides, analyzing 
additional significant predictors of AAA sac enlargement in a 
multivariable analysis in those over 80 years old, age was also 
considered one predisposing risk factor. In our study, there was 
no significant difference in sac enlargement between older and 
younger patients.
In our study, considering the retirement age in the public 
sector (70 years) and life expectancy in Portugal (81 years, 
according to the Global Health Observatory Data Repository, 
2012, http://apps.who.int/gho/data/node.main.688?lang=en), 
patients under 70 were considered young.
In contrast to randomized studies, with carefully selected 
patients, ours is a real-life study with all consecutive patients 
submitted to EVAR. There is a relevant difference in ASA physical 
status classification among our patients and others mentioned 
above. We can classify our population as ASA I (0%), ASA II (15.4%), 
ASA III (71%), and ≥ ASA IV (13.6%), compared to 10.6%, 65.6%, 
22.5%, and 1.3%, respectively, as reported by the ACE trials[5] and 
21.4%, 70.5%, 8.1%, and 0%, as described by the DREAM group[18].
Therapeutic choice was based on a set of parameters such 
as the surgical risk (both clinical and anatomic), the anatomical 
characteristics of the aneurysm, and the surgeon’s and patient’s 
option. Winterborn et al.[19], after a semistructured telephone 
interview with patients with small AAAs, concluded that the 
majority would prefer EVAR. Their major fears were the risk of 
organ failure and death. The type of incision, radiation exposure, 
and the risk of sexual dysfunction were ranked as the least 
important. Another three studies placed EVAR first among 
patients’ preferences, for whom lower short-term morbidity 
and mortality and a shorter length of stay took precedence 
over a higher risk of future reinterventions[19-21]. In our study, the 
surgeons’ and patients’ preferences for EVAR were statistically 
relevant in the younger group.
Another factor was relevant among age groups, and it may 
have had an impact on therapeutic choice: erectile dysfunction 
was significantly more frequent in older patients. As described 
elsewhere, sexual function deterioration is more frequent after 
open surgery[22]. So, we can assume that for younger patients, 
with preserved sexual activity, EVAR could be a better solution, 
as long as the internal iliac artery is preserved, as it does not 
interfere with parasympathetic chains and has a lower risk of 
producing sexual dysfunction.
During hospitalization, older patients needed a great number 
of blood transfusions. This difference was statistically significant 
and may suggest lower rates of early complications in younger 
patients. We haven’t observed different costs between different 
age groups.
Obesity is a known risk factor for open surgery, and it is 
associated with worse outcomes. As published in a meta-
analysis, after a review of 4 studies with a total of 2440 patients, 
30-day postoperative mortality was statistically higher with open 
surgery, as was myocardial infarction, chest infection, renal failure, 
and wound infection, compared to obese patients submitted to 
EVAR[23]. In our study, one-third of the younger group was obese 
and, in these patients, EVAR is favored over open surgery.
Table 7. Mean operative costs for patients undergoing EVAR. 
Mean Median Std. Deviation Minimum Maximum
EVAR <70 years 11,658 € 10,226.80 € 6,157.80 € 9,270 € 50,779.70 €
70-80 years 11,110.30 € 10,484.70 € 2,163 € 9,433 € 20,979 €
>80 years 11,521.80 € 10,371.30 € 4,752.80 € 9,081.50 € 40,240.70 €
No statistical significance.
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Veith et al.[24], arguing against level 1 studies, had no doubts: 
in fit patients with suitable anatomy, and when performed with 
requisite skills, facilities, and equipment, “do it by endovascular 
aneurysm repair!”. Their position is based on several points: first, 
we do it better than we did it when we started, so the actual 
results are better than those published 10 years ago, and we still 
considered level 1 evident (EVAR-1, OVER); second, endoprotheses 
are better, with lower migration and late failure and, finally, now 
we know and understand complications and we treat them in 
a useful time period (in EVAR-1, all endoleaks were considered 
complications and many complications were detected but left 
untreated). Also EVAR processing technical details have been 
improved, as recently stated by Molinari et al.[25], who concluded 
that as time goes by, the level of performance has increased and 
interventional procedures are done more efficiently, with less 
contrast injections and exposure to ionizing radiation.
CONCLUSION
Analyzing our experience, the absence of statistical 
differences between mortality and reinterventions between 
different age groups reveals that age itself is not a relevant factor 
in EVAR outcomes. Indeed, the three characteristics statistically 
different in younger patients (obesity, sexual function, and 
patient’s choice) can favour EVAR. No other clinical variables, 
surgical reintervention, mortality or costs were statistically 
different among age groups. Thus, we can suggest that age 
is not important as association to procedure-related EVAR 
outcomes when compared to older patients, and thereby may 
not be decisive in surgeon’s choice towards EVAR in a younger 
population; however, the limitations of the retrospective analysis 
must be considered.
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